WO1994005703A1 - Monoclonal antibody to cell surface protein of the bacterium neisseria meningitidis - Google Patents
Monoclonal antibody to cell surface protein of the bacterium neisseria meningitidis Download PDFInfo
- Publication number
- WO1994005703A1 WO1994005703A1 PCT/US1993/008048 US9308048W WO9405703A1 WO 1994005703 A1 WO1994005703 A1 WO 1994005703A1 US 9308048 W US9308048 W US 9308048W WO 9405703 A1 WO9405703 A1 WO 9405703A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- meningitidis
- fragment
- antibody
- antigen
- isolating
- Prior art date
Links
- 241000588650 Neisseria meningitidis Species 0.000 title claims abstract description 70
- 108010052285 Membrane Proteins Proteins 0.000 title abstract description 6
- 102000018697 Membrane Proteins Human genes 0.000 title abstract description 6
- 102000036639 antigens Human genes 0.000 claims abstract description 36
- 108091007433 antigens Proteins 0.000 claims abstract description 36
- 239000000427 antigen Substances 0.000 claims abstract description 33
- 210000004408 hybridoma Anatomy 0.000 claims abstract description 12
- 210000004027 cell Anatomy 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 31
- 239000012634 fragment Substances 0.000 claims description 21
- 102000004169 proteins and genes Human genes 0.000 claims description 21
- 108090000623 proteins and genes Proteins 0.000 claims description 21
- 241000894006 Bacteria Species 0.000 claims description 18
- 238000002965 ELISA Methods 0.000 claims description 9
- 229960005486 vaccine Drugs 0.000 claims description 9
- 238000001514 detection method Methods 0.000 claims description 8
- 241000588653 Neisseria Species 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 5
- 201000000050 myeloid neoplasm Diseases 0.000 claims description 5
- 210000004989 spleen cell Anatomy 0.000 claims description 5
- 241001529936 Murinae Species 0.000 claims description 4
- 238000003556 assay Methods 0.000 claims description 4
- 208000015181 infectious disease Diseases 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- 238000001952 enzyme assay Methods 0.000 claims description 3
- 238000003119 immunoblot Methods 0.000 claims description 3
- 230000009257 reactivity Effects 0.000 claims description 3
- 230000001900 immune effect Effects 0.000 claims description 2
- 238000002372 labelling Methods 0.000 claims description 2
- 239000012472 biological sample Substances 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 4
- 241000124008 Mammalia Species 0.000 claims 3
- 210000000628 antibody-producing cell Anatomy 0.000 claims 3
- 238000007818 agglutination assay Methods 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 description 18
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 239000006228 supernatant Substances 0.000 description 9
- 239000000499 gel Substances 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 108060003951 Immunoglobulin Proteins 0.000 description 6
- 102000018358 immunoglobulin Human genes 0.000 description 6
- 239000000020 Nitrocellulose Substances 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 229920001220 nitrocellulos Polymers 0.000 description 5
- 239000000243 solution Substances 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 241000588677 Neisseria meningitidis serogroup B Species 0.000 description 2
- 101710116435 Outer membrane protein Proteins 0.000 description 2
- 101710160107 Outer membrane protein A Proteins 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000007330 chocolate agar Substances 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000000521 hyperimmunizing effect Effects 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical compound C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 description 1
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
- HKJKONMZMPUGHJ-UHFFFAOYSA-N 4-amino-5-hydroxy-3-[(4-nitrophenyl)diazenyl]-6-phenyldiazenylnaphthalene-2,7-disulfonic acid Chemical compound OS(=O)(=O)C1=CC2=CC(S(O)(=O)=O)=C(N=NC=3C=CC=CC=3)C(O)=C2C(N)=C1N=NC1=CC=C([N+]([O-])=O)C=C1 HKJKONMZMPUGHJ-UHFFFAOYSA-N 0.000 description 1
- TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102000003846 Carbonic anhydrases Human genes 0.000 description 1
- 108090000209 Carbonic anhydrases Proteins 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 102000018251 Hypoxanthine Phosphoribosyltransferase Human genes 0.000 description 1
- 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 206010027202 Meningitis bacterial Diseases 0.000 description 1
- 206010027249 Meningitis meningococcal Diseases 0.000 description 1
- 201000010924 Meningococcal meningitis Diseases 0.000 description 1
- 241000588655 Moraxella catarrhalis Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000588654 Neisseria cinerea Species 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 241000609499 Palicourea Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241001486234 Sciota Species 0.000 description 1
- 241000271486 Sistrurus catenatus Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 229960003896 aminopterin Drugs 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 201000009904 bacterial meningitis Diseases 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 238000009640 blood culture Methods 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 238000012754 cardiac puncture Methods 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000006781 columbia blood agar Substances 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000002480 immunoprotective effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000037941 meningococcal disease Diseases 0.000 description 1
- 229940124731 meningococcal vaccine Drugs 0.000 description 1
- 229960005037 meningococcal vaccines Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000001989 nasopharynx Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 235000021241 α-lactalbumin Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU50936/93A AU5093693A (en) | 1992-08-31 | 1993-08-31 | Monoclonal antibody to cell surface protein of the bacterium neisseria meningitidis |
EP93920369A EP0625165A1 (en) | 1992-08-31 | 1993-08-31 | Monoclonal antibody to cell surface protein of the bacterium neisseria meningitidis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93718792A | 1992-08-31 | 1992-08-31 | |
US07/937,187 | 1992-08-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1994005703A1 true WO1994005703A1 (en) | 1994-03-17 |
WO1994005703A9 WO1994005703A9 (en) | 1994-06-09 |
Family
ID=25469608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1993/008048 WO1994005703A1 (en) | 1992-08-31 | 1993-08-31 | Monoclonal antibody to cell surface protein of the bacterium neisseria meningitidis |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0625165A1 (en) |
AU (1) | AU5093693A (en) |
CA (1) | CA2122630A1 (en) |
WO (1) | WO1994005703A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2720408A1 (en) * | 1994-05-31 | 1995-12-01 | Pasteur Merieux Serums Vacc | Polypeptide(s) for vaccination against Neisseria meningitidis group B |
WO1996029412A1 (en) | 1995-03-17 | 1996-09-26 | Biochem Vaccines Inc. | Proteinase k resistant surface protein of neisseria meningitidis |
WO1998002547A3 (en) * | 1996-07-12 | 1998-04-09 | Inst Nat Sante Rech Med | Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
US6287574B1 (en) | 1995-03-17 | 2001-09-11 | Biochem Pharma Inc. | Proteinase K resistant surface protein of neisseria meningitidis |
CN100387718C (en) * | 1995-03-17 | 2008-05-14 | 益得生物医学公司 | Proteinase K resistant surface protein of neisseria meningitidis |
-
1993
- 1993-08-31 AU AU50936/93A patent/AU5093693A/en not_active Abandoned
- 1993-08-31 EP EP93920369A patent/EP0625165A1/en not_active Withdrawn
- 1993-08-31 WO PCT/US1993/008048 patent/WO1994005703A1/en not_active Application Discontinuation
- 1993-08-31 CA CA002122630A patent/CA2122630A1/en not_active Abandoned
Non-Patent Citations (2)
Title |
---|
Infection and Immunity, Volume 43, No. 3, issued March 1984, J.G. CANNON et al.: "Monoclonal Antibody that Recognizes an Outer Membrane Antigen Common to the Pathogenic Neisseria Species but no to Most Nonpathogenic Neisseria Species", pages 994-999, see entire document. * |
Infection and Immunity, Volume 50, No. 2, issued November 1985, B.R. BRODEUR et al.: "Protection against Infection with Neisseria meningitidis Group B Serotype 2b by Passive Immunization with Serotype-Specific Monoclonal Antibody", pages 510-516, see entire document. * |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2720408A1 (en) * | 1994-05-31 | 1995-12-01 | Pasteur Merieux Serums Vacc | Polypeptide(s) for vaccination against Neisseria meningitidis group B |
WO1995033049A2 (en) * | 1994-05-31 | 1995-12-07 | Pasteur Merieux Serums Et Vaccins | Tbp2 FRAGMENTS OF THE TRANSFERRINE RECEPTOR OF NEISSERIA MENINGITIDIS |
WO1995033049A3 (en) * | 1994-05-31 | 1996-01-04 | Pasteur Merieux Serums Vacc | Tbp2 fragments of the transferrine receptor of neisseria meningitidis |
US7273611B1 (en) | 1995-03-17 | 2007-09-25 | Id Biomedical Corporation | Proteinase K resistant surface protein of neisseria meningitidis |
US7786286B2 (en) | 1995-03-17 | 2010-08-31 | Id Biomedical Corporation | Proteinase K resistant surface protein of Neisseria meningitidis |
AU716225B2 (en) * | 1995-03-17 | 2000-02-24 | Id Biomedical Corporation | Proteinase K resistant surface protein of neisseria meningitidis |
US6287574B1 (en) | 1995-03-17 | 2001-09-11 | Biochem Pharma Inc. | Proteinase K resistant surface protein of neisseria meningitidis |
AP1027A (en) * | 1995-03-17 | 2001-11-23 | Iaf Biochem Int | Protein K resistant surface protein of neisseria meningitidis. |
US7833717B2 (en) | 1995-03-17 | 2010-11-16 | Id Biomedical Corporation | Proteinase K resistant surface protein of Neisseria meningitidis |
CZ298052B6 (en) * | 1995-03-17 | 2007-06-06 | Id Biomedical Corporation | Isolated Neisseria surface peptide, use thereof, vaccine and process for preparing such vaccine |
WO1996029412A1 (en) | 1995-03-17 | 1996-09-26 | Biochem Vaccines Inc. | Proteinase k resistant surface protein of neisseria meningitidis |
CZ298646B6 (en) * | 1995-03-17 | 2007-12-05 | Id Biomedical Corporation | Polynucleotide, use thereof and Neisseria polypeptide encoded thereby |
EP2241625A1 (en) * | 1995-03-17 | 2010-10-20 | ID Biomedical Corporation | Proteinase K resistant surface protein of neisseria meningitidis |
CN100387718C (en) * | 1995-03-17 | 2008-05-14 | 益得生物医学公司 | Proteinase K resistant surface protein of neisseria meningitidis |
US7749499B2 (en) | 1995-03-17 | 2010-07-06 | Id Biomedical Corporation | Proteinase K resistant surface protein of Neisseria meningitidis |
US7776335B2 (en) | 1995-03-17 | 2010-08-17 | Id Biomedical Corporation | Proteinase K resistant surface protein of Neisseria meningitidis |
US7029845B2 (en) | 1996-07-12 | 2006-04-18 | Institut National De La Sante Et De La Recherche Medicale (I.N.S.E.R.M.) | DNAs and proteins or peptides specific to bacteria of the species Neisseria meningitidis, processes for obtaining them and their biological uses |
US7368556B2 (en) | 1996-07-12 | 2008-05-06 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof |
WO1998002547A3 (en) * | 1996-07-12 | 1998-04-09 | Inst Nat Sante Rech Med | Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
US8357791B2 (en) | 1996-07-12 | 2013-01-22 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof |
Also Published As
Publication number | Publication date |
---|---|
CA2122630A1 (en) | 1994-03-17 |
EP0625165A1 (en) | 1994-11-23 |
AU5093693A (en) | 1994-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pettersson et al. | Monoclonal antibodies against the 70-kilodalton iron-regulated protein of Neisseria meningitidis are bactericidal and strain specific | |
JP4353789B2 (en) | Staphylococcus epidermidis type I and type II surface antigens | |
Brodeur et al. | Protection against infection with Neisseria meningitidis group B serotype 2b by passive immunization with serotype-specific monoclonal antibody | |
Klingman et al. | Purification and characterization of a high-molecular-weight outer membrane protein of Moraxella (Branhamella) catarrhalis | |
EP0482176B1 (en) | Monoclonal antibodies specific for toxin b of clostridium difficile | |
Robertson et al. | Monoclonal antibodies directed against a cell surface-exposed outer membrane protein of Haemophilus influenzae type b | |
Miner et al. | Characterization of murine monoclonal antibodies to Escherichia coli J5 | |
Lopez-Vidal et al. | Monoclonal antibodies against the different subcomponents of colonization factor antigen II of enterotoxigenic Escherichia coli | |
Morrison-Plummer et al. | Biological effects of anti-lipid and anti-protein monoclonal antibodies on Mycoplasma pneumoniae | |
Wnek et al. | Production and characterization of monoclonal antibodies against Clostridium perfringens type A enterotoxin | |
US5641638A (en) | Monoclonal antibodies against Mycoplasma pneumoniae, hybridomas producing these, methods for the preparation thereof, and the use thereof | |
Bhushan et al. | Antigenic characterization and analysis of the human immune response to outer membrane protein E of Branhamella catarrhalis | |
Sadallah et al. | Production of specific monoclonal antibodies to Salmonella typhi flagellin and possible application to immunodiagnosis of typhoid fever | |
Sørensen et al. | Phosphorylcholine determinants in six pneumococcal capsular polysaccharides detected by monoclonal antibody | |
Hamilton et al. | Evidence that the M antigen of Histoplasma capsulatum var. capsulatum is a catalase which exhibits cross-reactivity with other dimorphic fungi | |
WO1998006432A1 (en) | Outer membrane protein b1 of moraxella catarrhalis | |
US5322788A (en) | Monoclonal anti-body to cell surface protein of the bacterium Streptococcus pneumoniae | |
Martin et al. | Immunological characterization of the lipooligosaccharide B band of Bordetella pertussis | |
WO1994005703A1 (en) | Monoclonal antibody to cell surface protein of the bacterium neisseria meningitidis | |
WO1994005703A9 (en) | Monoclonal antibody to cell surface protein of the bacterium neisseria meningitidis | |
Worsaae et al. | Monoclonal antibodies produced in BALB. B10 mice define new antigenic determinants in culture filtrate preparations of Mycobacterium tuberculosis | |
Helsel et al. | Recognition of a genus-wide antigen of Legionella by a monoclonal antibody | |
Poolman et al. | Description of a hybridoma bank towards Bordetella pertussis toxin and surface antigens | |
Eisenstein et al. | Isolation and characterization of a monoclonal antibody directed against type 1 fimbriae organelles from Escherichia coli | |
US5013664A (en) | Common protein of Haemophilus influenzae type b identified by a monoclonal antibody |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BB BG BR CA CZ FI HU JP KP KR KZ LK MG MN MW NO NZ PL RO RU SD SK UA VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2122630 Country of ref document: CA Ref document number: 255901 Country of ref document: NZ Ref document number: 1993920369 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1993920369 Country of ref document: EP |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1-17,DESCRIPTION,REPLACED BY NEW PAGES 1-14;PAGE 18,CLAIMS,REPLACED BY NEW PAGE 15;PAGES 19-22,AMENDED CLAIMS,RENUMBERED AS PAGES 23-26;AFTER RECTIFICATION OF OBVIOUS ERRORS AS AUTHORIZED BY THE INTERNATIONAL SEARCHING AUTHORITY |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
COP | Corrected version of pamphlet |
Free format text: PAGES 1-17,DESCRIPTION,REPLACED BY NEW PAGES 1-14;PAGE 18,CLAIMS,REPLACED BY NEW PAGE 15;PAGES 19-22,AMENDED CLAIMS,RENUMBERED AS PAGES 16-19;AFTER RECTIFICATION OF OBVIOUS ERRORS AS AUTHORIZED BY THE INTERNATIONAL SEARCHING AUTHORITY |
|
WWP | Wipo information: published in national office |
Ref document number: 1993920369 Country of ref document: EP |